GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Scaled Net Operating Assets

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Scaled Net Operating Assets : 0.43 (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nobel Biocare Holding AG's operating assets for the quarter that ended in Dec. 2013 was $583.4 Mil. Nobel Biocare Holding AG's operating liabilities for the quarter that ended in Dec. 2013 was $241.9 Mil. Nobel Biocare Holding AG's Total Assets for the quarter that ended in Dec. 2012 was $788.8 Mil. Therefore, Nobel Biocare Holding AG's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2013 was 0.43.


Nobel Biocare Holding AG Scaled Net Operating Assets Historical Data

The historical data trend for Nobel Biocare Holding AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Scaled Net Operating Assets Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.42 0.39 0.44 0.43

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.42 0.39 0.44 0.43

Competitive Comparison of Nobel Biocare Holding AG's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Scaled Net Operating Assets falls into.



Nobel Biocare Holding AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nobel Biocare Holding AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2013 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2013 )
=(Operating Assets (A: Dec. 2013 )-Operating Liabilities (A: Dec. 2013 ))/Total Assets (A: Dec. 2012 )
=(583.435-241.911)/788.762
=0.43

where

Operating Assets(A: Dec. 2013 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=835.514 - 252.079
=583.435

Operating Liabilities(A: Dec. 2013 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=376.462 - 134.551 - 0
=241.911

Nobel Biocare Holding AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2013 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2013 )
=(Operating Assets (Q: Dec. 2013 )-Operating Liabilities (Q: Dec. 2013 ))/Total Assets (Q: Dec. 2012 )
=(583.435-241.911)/788.762
=0.43

where

Operating Assets(Q: Dec. 2013 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=835.514 - 252.079
=583.435

Operating Liabilities(Q: Dec. 2013 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=376.462 - 134.551 - 0
=241.911

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobel Biocare Holding AG Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines